Loading clinical trials...
Loading clinical trials...
An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases
Conditions
Interventions
D961H sachet 10 mg
D961H capsule 10mg
+1 more
Locations
15
Japan
Research Site
Bunkyō City, Japan
Research Site
Fukuoka, Japan
Research Site
Hiroshima, Japan
Research Site
Izumi-shi, Japan
Research Site
Maebashi, Japan
Research Site
Matsumoto-shi, Japan
Start Date
June 1, 2014
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2016
Last Updated
January 19, 2017
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions